[HLFG] QoQ Annualized Quarter Result on 30-Sep-2011 [#1]

Announcement Date
30-Nov-2011
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2012
Quarter
30-Sep-2011 [#1]
Profit Trend
QoQ- -46.94%
YoY- -31.44%
View:
Show?
Annualized Quarter Result
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Revenue 4,158,163 4,160,464 3,961,384 3,581,388 3,665,505 3,616,420 4,146,718 0.18%
PBT 2,393,748 2,443,608 1,950,286 1,962,492 2,422,684 2,542,080 3,035,346 -14.65%
Tax -540,310 -549,586 -451,584 -493,444 -350,817 -321,322 -417,196 18.83%
NP 1,853,438 1,894,021 1,498,702 1,469,048 2,071,867 2,220,757 2,618,150 -20.58%
-
NP to SH 1,233,568 1,303,950 929,394 887,928 1,673,579 1,835,800 2,224,522 -32.52%
-
Tax Rate 22.57% 22.49% 23.15% 25.14% 14.48% 12.64% 13.74% -
Total Cost 2,304,725 2,266,442 2,462,682 2,112,340 1,593,638 1,395,662 1,528,568 31.52%
-
Net Worth 8,897,207 7,255,878 7,258,238 7,265,078 7,467,605 7,298,340 7,052,604 16.76%
Dividend
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Div 259,848 345,518 207,378 415,147 290,406 386,484 207,124 16.33%
Div Payout % 21.06% 26.50% 22.31% 46.75% 17.35% 21.05% 9.31% -
Equity
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Net Worth 8,897,207 7,255,878 7,258,238 7,265,078 7,467,605 7,298,340 7,052,604 16.76%
NOSH 1,039,393 1,036,554 1,036,891 1,037,868 1,037,167 1,035,225 1,035,624 0.24%
Ratio Analysis
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
NP Margin 44.57% 45.52% 37.83% 41.02% 56.52% 61.41% 63.14% -
ROE 13.86% 17.97% 12.80% 12.22% 22.41% 25.15% 31.54% -
Per Share
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
RPS 400.06 401.37 382.04 345.07 353.41 349.34 400.41 -0.05%
EPS 118.60 125.73 89.60 85.60 161.40 177.33 214.80 -32.72%
DPS 25.00 33.33 20.00 40.00 28.00 37.33 20.00 16.05%
NAPS 8.56 7.00 7.00 7.00 7.20 7.05 6.81 16.48%
Adjusted Per Share Value based on latest NOSH - 1,037,868
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
RPS 366.43 366.64 349.09 315.61 323.02 318.69 365.42 0.18%
EPS 108.71 114.91 81.90 78.25 147.48 161.78 196.03 -32.52%
DPS 22.90 30.45 18.27 36.58 25.59 34.06 18.25 16.35%
NAPS 7.8405 6.3941 6.3962 6.4023 6.5807 6.4316 6.215 16.76%
Price Multiplier on Financial Quarter End Date
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Date 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 31/03/11 30/12/10 -
Price 12.24 12.30 11.66 10.90 13.18 9.00 8.89 -
P/RPS 3.06 3.06 3.05 3.16 3.73 2.58 2.22 23.87%
P/EPS 10.31 9.78 13.01 12.74 8.17 5.08 4.14 83.82%
EY 9.70 10.23 7.69 7.85 12.24 19.70 24.16 -45.60%
DY 2.04 2.71 1.72 3.67 2.12 4.15 2.25 -6.32%
P/NAPS 1.43 1.76 1.67 1.56 1.83 1.28 1.31 6.02%
Price Multiplier on Announcement Date
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Date 28/08/12 16/05/12 27/02/12 30/11/11 26/08/11 10/05/11 23/02/11 -
Price 12.18 11.72 11.76 11.40 11.68 11.14 8.80 -
P/RPS 3.04 2.92 3.08 3.30 3.30 3.19 2.20 24.08%
P/EPS 10.26 9.32 13.12 13.33 7.24 6.28 4.10 84.42%
EY 9.74 10.73 7.62 7.50 13.82 15.92 24.41 -45.83%
DY 2.05 2.84 1.70 3.51 2.40 3.35 2.27 -6.57%
P/NAPS 1.42 1.67 1.68 1.63 1.62 1.58 1.29 6.61%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment